2015
DOI: 10.1039/c4cc10074c
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold

Abstract: Hsp90 C-terminal ligands are potential new anti-cancer drugs alternative to the more studied N-terminal inhibitors. Here we report the identification of a new dihydropyrimidinone binding the C-terminus, which is not structurally related to other well-known natural and nature-inspired inhibitors of this second druggable Hsp90 site.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 32 publications
(31 citation statements)
references
References 38 publications
0
31
0
Order By: Relevance
“…These results are confirmed by only few past experiences, in which the "earliest" delayed scans (8-12 min) were considered suitable to evaluate the lesion enhancement (8,19). Moreover, these results have a remarkable technical implication because allow optimizing the scanning protocols reducing the CT acquisitions and improving the diagnosis of parotid gland lesions, especially where the biopsy is not easy to perform (23)(24)(25)(26)(27)(28)(29)(30)(31)(32). However, we did not find a correlation between the lesion attenuation ratio of pleomorphic adenomas and the malignant tumours in our study population.…”
Section: A B Cmentioning
confidence: 64%
“…These results are confirmed by only few past experiences, in which the "earliest" delayed scans (8-12 min) were considered suitable to evaluate the lesion enhancement (8,19). Moreover, these results have a remarkable technical implication because allow optimizing the scanning protocols reducing the CT acquisitions and improving the diagnosis of parotid gland lesions, especially where the biopsy is not easy to perform (23)(24)(25)(26)(27)(28)(29)(30)(31)(32). However, we did not find a correlation between the lesion attenuation ratio of pleomorphic adenomas and the malignant tumours in our study population.…”
Section: A B Cmentioning
confidence: 64%
“…[7,[32][33] Ac omparison between the cleavages ites ob- served on Hsp90a and on Hsp90a/1,H sp90a/3,a nd Hsp90a/5 complexes ( Figure 5) allowed the formulation of some hypothesis on the possible bindingr egion of the three compounds. This experimental strategy was previously used to study other Hsp90/inhibitor complexes.…”
Section: Identification Of the Hsp90 Regionr Esponsible For Molecularmentioning
confidence: 99%
“…The second set of compounds investigated were the 1phenyl-di(tetra)hydronaphthalene analogues (15)(16)(17)(18). Initially, the 1-phenyl-dihydronaphthalene scaffold was designed to compare placement of the phenylr ing on the 1-versus2 -position of the naphthalene ring.…”
Section: Design and Synthesis Of Novel Scaffoldsmentioning
confidence: 99%
“…[13,14] Therefore, the development of Hsp90 C-terminal inhibitors could provideaclinically useful alternative for the treatmento f cancer. [15][16][17][18][19] Studies have shown that natural product C-terminal inhibitors, [20][21][22][23][24] such as novobiocin and coumermycin A1, do not inducet he heat shock response. Unfortunately,t hese compounds manifestI C 50 values of 700 and 70 mm,r espectively.…”
Section: Introductionmentioning
confidence: 99%